5-[[4-(Diphenylamino)phenyl]methylene]-3-(2-phenylethyl)-2,4-oxazolidinedione
[CAS# 506426-96-6]

Identification

• Classification: Pharmaceutical intermediate >> OLED material intermediate
• Name: 5-[[4-(Diphenylamino)phenyl]methylene]-3-(2-phenylethyl)-2,4-oxazolidinedione
• Synonyms: (5Z)-5-[[4-(N-phenylanilino)phenyl]methylidene]-3-(2-phenylethyl)-1,3-oxazolidine-2,4-dione
• Molecular Formula: C₃₀H₂₄N₂O₃
• Molecular Weight: 460.52
• CAS Registry Number: 506426-96-6
• EC Number: 453-020-0
• SMILES: C1=CC=C(C=C1)CCN2C(=O)/C(=C/C3=CC=C(C=C3)N(C4=CC=CC=C4)C5=CC=CC=C5)/OC2=O

Properties

• Density: 1.3±0.1 g/cm³, Calc.^*
• Index of Refraction: 1.687, Calc.^*
• Boiling Point: 624.5±65.0 ºC (760 mmHg), Calc.^*
• Flash Point: 331.5±34.3 ºC, Calc.^*

^* Calculated using Advanced Chemistry Development (ACD/Labs) Software.

Discovory and Applicatios

5-[[4-(Diphenylamino)phenyl]methylene]-3-(2-phenylethyl)-2,4-oxazolidinedione is a synthetic organic compound that has drawn attention for its potential applications in the fields of material science and medicinal chemistry. Its discovery is linked to efforts to develop novel compounds with desirable properties, particularly in the areas of semiconductors and pharmaceuticals.

The compound was first synthesized as part of research aimed at developing new organic materials with enhanced optoelectronic properties. Its structure, characterized by the presence of a diphenylamino group and an oxazolidinedione ring, contributes to its ability to engage in conjugated systems. This makes it a candidate for applications in organic semiconductors and light-emitting devices. Researchers initially explored the compound’s properties for its potential use in organic light-emitting diodes (OLEDs) and similar technologies, where organic compounds can offer flexible and efficient alternatives to traditional materials.

In medicinal chemistry, 5-[[4-(Diphenylamino)phenyl]methylene]-3-(2-phenylethyl)-2,4-oxazolidinedione has been investigated for its pharmacological potential due to the presence of the oxazolidinedione ring. Compounds with this functional group are known for their activity as anticonvulsants, and as a result, this molecule has been studied for possible applications in the treatment of neurological disorders such as epilepsy. Research into its bioactivity and interaction with biological targets is ongoing, with preliminary findings suggesting that modifications to the molecule could enhance its medicinal properties.

The chemical synthesis of this compound involves complex organic reactions, typically starting with the formation of the oxazolidinedione ring, followed by the introduction of the diphenylamino and phenylethyl groups. Advances in synthetic organic chemistry have allowed for more efficient production of this compound, making it more accessible for further study and application in both material science and medicinal research.

While its full range of applications is still under exploration, 5-[[4-(Diphenylamino)phenyl]methylene]-3-(2-phenylethyl)-2,4-oxazolidinedione represents a promising candidate in the search for new organic materials and pharmaceutical agents. Its dual potential in optoelectronics and medicine highlights the versatility of such compounds, encouraging continued research into their properties and potential uses.